Cellectar Biosciences, Inc. (CLRB) Capital expenditures 2016–2025
Cellectar Biosciences, Inc. (CLRB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5,880FY2025 · since FY2016: $72,251 → $5,880
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5,880 | -94.4% |
| FY2024 | $104,195 | -87.9% |
| FY2023 | $864,038 | +282.4% |
| FY2022 | $225,971 | +59.9% |
| FY2021 | $141,361 | +126.7% |
| FY2020 | $62,353 | +154.1% |
| FY2019 | $24,542 | -93.6% |
| FY2018 | $384,993 | +11.0% |
| FY2017 | $346,703 | +379.9% |
| FY2016 | $72,251 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice